Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
100%(5 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
1
14%
Ph phase_2
1
14%
Ph early_phase_1
1
14%
Ph phase_4
3
43%
Ph phase_3
1
14%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
3(42.9%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 43 (42.9%)
N/A1 (14.3%)

Trials by Status

unknown114%
completed571%
terminated114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7